Shares in Immutep have leapt after the biotech reported phase 2b results showing that LAG-3 inhibitor eftilagimod alfa (efti) significantly boosted the efficacy of MSD’s Keytruda in patients ...
Her work has been featured in NewsWeek, Huffington Post and more.... A seasoned small business and technology writer and educator with more than 20 years of experience, Shweta excels in ...
It's advisable to try out a career before settling on it, so if you're in need of work experience ideas learn more about internships, online experience, work placements, shadowing, volunteering and ...